Results 131 to 140 of about 2,055 (188)
Increased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor. [PDF]
Kumar ARK +5 more
europepmc +1 more source
Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression. [PDF]
Kim JM +10 more
europepmc +1 more source
Biological activity of phthalazine sulfonamides
A.A. Zubenko +4 more
openaire +1 more source
A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC). [PDF]
Wang L +33 more
europepmc +1 more source
SLX1 silencing overcomes Olaparib resistance in metastatic castration-resistant prostate cancer by disrupting SLX4-mediated DNA repair complexes. [PDF]
Zhao X, Feng S, Nitie X, Muluo S, Lei Y.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
ChemInform, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
N. Haider, W. Holzer
openaire +1 more source
AbstractFor Abstract see ChemInform Abstract in Full Text.
N. Haider, W. Holzer
openaire +1 more source

